L1 vertebral density on CT is too variable with different scanning protocols to be a useful screening tool for osteoporosis in everyday practice.

Autor: Gerety EL; 1 Department of Radiology, Cambridge University Hospitals NHS Foundation Trust , Cambridge , UK., Bearcroft PW; 1 Department of Radiology, Cambridge University Hospitals NHS Foundation Trust , Cambridge , UK.

Publikováno v: The British journal of radiology [Br J Radiol] 2018 Apr; Vol. 91 (1084), pp. 20170395. Date of Electronic Publication: 2018 Jan 22.

Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.

Autor: Gerety EL; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Lawrence EM; Department of Radiology, University of Cambridge, Cambridge., Wason J; MRC Biostatistics Unit Hub for Trials Methodology, Cambridge., Yan H; Department of Radiology, University of Cambridge, Cambridge., Hilborne S; Department of Radiology, University of Cambridge, Cambridge., Buscombe J; Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Cheow HK; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Shaw AS; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Bird N; East Anglian Regional Radiation Protection Service, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Fife K; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Heard S; Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge., Lomas DJ; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge Department of Radiology, University of Cambridge, Cambridge., Matakidou A; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge., Soloviev D; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge., Eisen T; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge Department of Oncology, University of Cambridge, Cambridge, UK., Gallagher FA; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners, Cambridge Department of Radiology, University of Cambridge, Cambridge fag1000@cam.ac.uk.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Oct; Vol. 26 (10), pp. 2113-8. Date of Electronic Publication: 2015 Jul 22.